Computational comparison of two new fusion proteins for multiple sclerosis
Multiple sclerosis (MS), as one of the human autoimmune diseases, demyelinates the neurons of the central nervous system (CNS). Activation of the T cells which target the CNS antigens is the first autoimmune event in MS. Myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP) are tw...
Main Authors: | Nasrin Payab, Karim Mahnam, Mostafa Shakhsi-Niaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2018;volume=13;issue=5;spage=394;epage=403;aulast=Payab |
Similar Items
-
Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease
by: Fatemeh Banisharif-Dehkordi, et al.
Published: (2019-01-01) -
Die Bedeutung von Serum-Antikörpern gegen Myelinproteine vor Erstmanifestation einer Multiplen Sklerose
by: Franke, Corinna
Published: (2014) -
Stable Transfection of pEGFP-N1-MOG Plasmid to Utilize in Multiple Sclerosis Gene Therapy
by: Mohammad Hassan Karimfar, et al.
Published: (2015-02-01) -
The Predictive Role of Neurobiochemical Markers in Multiple Sclerosis
by: Esra Fırat Oğuz, et al.
Published: (2020-01-01) -
Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens
by: Maria Rodi, et al.
Published: (2016-08-01)